1. 998TiPPamiparib, a novel PARP 1/2 inhibitor, monotherapy for gBRCAm patients with recurrent ovarian, fallopian, and primary peritoneal cancer: An open-label, multicenter, phase II trial in China. (23rd October 2018) Authors: Wu, X; Wang, J; Zhou, Q; Gu, T; Zhang, K; Liang, J; Mu, S; Ge, R; Yang, H; Huang, V; Brachmann, R; Wang, L; Li, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 421PPreliminary results of pamiparib (BGB-290), a PARP1/2 inhibitor, in combination with temozolomide (TMZ) in patients (pts) with locally advanced or metastatic solid tumors. (23rd October 2018) Authors: Johnson, M; Galsky, M; Barve, M; Goel, S; Park, H; Du, B; Mu, S; Ramakrishnan, V; Wood, K; Wang, V; Lakhani, N Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Age‐specific reference ranges of serum anti‐müllerian hormone in healthy women and its application in diagnosis of polycystic ovary syndrome: a population study. (25th February 2020) Authors: Li, HWR; He, Y‐L; Li, R; Wong, CYG; Sy, B; Lam, CW; Lam, KSL; Peng, H‐M; Mu, S; Schooling, M; Yeung, WSB; Ho, PC; Ng, EHY Journal: BJOG Issue: Volume 127:Number 6(2020) Page Start: 720 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. O-017 Recurrent Intracranial Vertebral Artery Dissecting Aneurysms After Stent-assisted Coil Embolization-A Computational Fluid Dynamic Analysis. (29th July 2016) Authors: Liu, J; Jing, L; Zhang, Y; Song, Y; Wang, Y; Li, C; Wang, Y; Mu, S; Paliwal, N; Meng, H; Linfante, I; Yang, X Journal: Journal of neurointerventional surgery Issue: Volume 8(2016)Supplement 1 Page Start: A11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P564 A qualitative exploration of acceptability of long-term use of oral nutritional supplement drinks as partial enteral nutrition in adolescent and adult Crohn's Disease. (21st January 2022) Authors: Mu, S; Wei, Y; Weekes, E; Keetarut, K Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i507 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. On the Accuracy of the Composition-by-difference Method for Determining Lithium Content in Oxides. (August 2022) Authors: Lee, J; Mu, S; Stowe, DJ Journal: Microscopy and microanalysis Issue: Volume 28(2022)Supplement 1 Page Start: 548 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Asbestos related diseases from environmental exposure to crocidolite in Da-yao, China. I. Review of exposure and epidemiological data. (1st January 2003) Authors: Luo, S; Liu, X; Mu, S; Tsai, S P; Wen, C P Journal: Occupational and environmental medicine Issue: Volume 60(2003)Supplement 1 Page Start: 35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Surface-induced spin state locking of the [Fe(H2B(pz)2)2(bipy)] spin crossover complex. (27th April 2016) Authors: Beniwal, S; Zhang, X; Mu, S; Naim, A; Rosa, P; Chastanet, G; Létard, J-F; Liu, J; Sterbinsky, G E; Arena, D A; Dowben, P A; Enders, A Journal: Journal of physics Issue: Volume 28:Number 20(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗